www.fdanews.com/articles/126998-meda-acquires-exclusive-rights-to-new-treatment-of-actinic-keratosis

Meda Acquires Exclusive Rights to New Treatment of Actinic Keratosis

May 12, 2010

Meda has acquired exclusive European rights to a new formulation of imiquimod from Graceway Pharmaceuticals.
StreetInsider